H

Humana

Sells Medicare health plans and runs senior clinics

Lead AI Technical Product Manager

Full-Time
$151.6k - $208.4k/yr+ Bonus incentive
Senior
Bachelor's, Master's
Boston, MA, USA+4 moreMore locations: Louisville, KY, USA | Washington, DC, USA | Chicago, IL, USA | New York, NY, USA
HybridThree days per week in the office; must reside within or relocate to a commutable distance from a listed talent market.
ProductTechnical Product Management

About the job

Requirements
  • A B.S. or M.S. in Computer Science, Engineering, or a related field, or equivalent experience.
  • At least 7 years of product or related experience, including at least 4 years in product management, with AI/ML or GenAI products shipped to production.
  • Regularly use AI tools, articulate specifically what should change about a model's behavior and why, and prototype ideas.
  • Have built evaluations, including golden sets, ground truth, and offline and live evaluations, and used precision- and recall-based metrics to make product decisions.
  • Apply systems thinking by building infrastructure that prevents entire classes of problems.
  • Move between business and technical concepts, with a track record of business cases, ROI models, and roadmaps that inform investment decisions.
  • Have a working understanding of modern AI/ML and GenAI, including large language models, agents, retrieval-augmented generation, prompt engineering, and evaluation methodology, and how these apply to enterprise problems.
Responsibilities
  • Define the vision, strategy, and roadmap for a complex AI product area; decide what to build and why, prioritize competing opportunities, and adapt as the model landscape and business change.
  • Partner directly with business units to map operations end to end through service design, then translate ambiguous business problems into scoped AI use cases with a value proposition, business case, and ROI justification.
  • Build working prototypes and demos using agentic coding and AI tools such as Claude Code, Cursor, or OpenAI Codex to test feasibility and value before committing a full team.
  • Turn validated use cases into buildable requirements, user stories, acceptance criteria, edge cases, and success metrics; shape the end-to-end user experience with design.
  • Drive delivery from prototype to production, own the backlog, sequence work, make scope and tradeoff decisions as models and constraints shift, unblock the team, and maintain momentum from demo through launch and iteration.
  • Define and measure quality by building golden sets and ground truth, running offline and live production evaluations, choosing appropriate metrics such as accuracy, precision, recall, F1, task success, and hallucination rate, applying LLM-as-judge when validated, and turning results into launch decisions and leadership readouts.
  • Support high-level architecture and feasibility discussions with engineering while owning required prompt engineering and/or skill creation components of the AI harness.
  • Lead engineers, data scientists, designers, and business partners without direct authority; author reusable playbooks, skills, and solution patterns to make AI delivery faster and more consistent.
  • Move solutions through Humana's enterprise AI governance process, owning product documentation, scorecards, and stage-gate reviews.
  • Communicate strategy, requirements, roadmap, ROI, and evaluation results to executive and technical audiences; mentor product managers and raise the team's standard for building with AI.
  • Track advances in models, agents, evaluations, and emerging techniques such as agent harnesses, loops, and graph/GraphRAG approaches, and apply them in the portfolio.
  • Ensure all AI solutions comply with Humana's Enterprise AI Governance Framework and undergo full review at designated stage gates.
Desired Qualifications
  • Experience in healthcare, insurance, or another regulated industry.
  • A well-supported point of view on the direction of agentic AI, evaluations, and AI-native product development.
  • Hands-on experience with agent frameworks, GraphRAG or knowledge graphs, and reusable skills or plugins.
  • Comfort working from first principles amid ambiguity and at a fast pace.

About the company

H

Humana

View
Website

Humana sells health insurance paid for by government programs, chiefly Medicare Advantage plans that private insurers run for Americans 65 and older in place of traditional Medicare. It ranks among the largest Medicare Advantage insurers in the country and also runs Medicaid plans for low-income families in several states. Its CenterWell business operates senior primary care clinics, a mail-order pharmacy and home health services, so many members get care from a company the insurer owns. Medicare and states pay Humana a set monthly amount per member, and it keeps the difference between those payments and members' medical costs. Humana was founded in 1961 as a nursing home company and is based in Louisville, Kentucky.

Company Size

10,001+

Company Stage

IPO

Headquarters

Louisville, Kentucky

Founded

1961

Get referred to Humana

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Enrollment is surging: in July 2026 Humana affirmed about 25% individual Medicare Advantage membership growth for 2026.
  • Owned clinics create clinical careers: CenterWell Senior Primary Care added 130,900 patients, up 27%, in early 2026.
  • Medicaid is widening: Illinois chose Humana in June 2026 to run Medicaid coverage statewide.

What critics are saying

  • Low quality scores cut Medicare bonuses: only 20% of Humana's members sat in 4-star or better plans for 2026.
  • The insurer is shrinking to save margins: about 600,000 Medicare Advantage members got plan-closure notices in October 2026.
  • Stock grants carry risk: in July 2026 Humana cut its 2026 GAAP earnings floor to $6.52 a share from $8.36.

What makes Humana unique

  • Military families are a second market: Humana runs the Pentagon's TRICARE health plan across 24 eastern states and Washington, DC.
  • Florida anchors the business: Humana's Medicare Advantage contracts there produced 14% of its 2025 revenue.
  • Medicaid is a quiet second insurer: Humana covers over 1.54 million low-income members across 11 states.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Life Insurance
  • Disability Insurance
  • Unlimited Paid Time Off
  • Paid Vacation
  • Paid Parental Leave
  • Short-term Disability
  • Long-term Disability
  • 401(k) Retirement Plan
  • 401(k) Company Match

Growth & Insights and Company News

6 month growth

2%

1 year growth

6%

2 year growth

6%
Yahoo Finance
Oct 20th, 2026
UnitedHealth and Humana raise drug costs 30% as older Americans face pricier Medicare

US insurers including UnitedHealth and Humana are cutting benefits for older clients and raising prescription drug costs for 2027, weeks before the midterm elections. Both insurers scrapped hundreds of plans and tightened coverage as older voters began choosing their plans. UnitedHealth and Humana raised maximum out-of-pocket costs by 11% and 8% respectively, according to investment bank Leerink. Both raised prescription drug coverage costs by about 30%. The changes affect 35 million Americans on Medicare Advantage plans, and the two firms hold about 46% of that market. The changes should help insurers' profits. UnitedHealth's healthcare division operating margin rose to 3.3% from 2.1% a year earlier, and Humana's shares are up 57% this year.

Yahoo Finance
Oct 9th, 2026
Humana soars 15% as 95% of Medicare members join four-star plans, beating analyst expectations

Humana shares surged 15% after the insurer announced 95% of its Medicare Advantage members will be in plans rated four stars or higher for 2027, up from just 20% a year ago. The result significantly exceeded J.P. Morgan analysts' expectations of 60% to 70%. Plans with four-star ratings or higher qualify for government bonus payments worth billions across the industry. The industry average for 2027 stands at roughly 71%. However, these ratings will determine bonus payments for 2028, not 2027. The improved ratings are particularly significant given Humana's thin margins. The company's EBIT margin has declined from 4.3% in 2023 to 2.3% on a last-twelve-months basis. Meanwhile, competitors moved in the opposite direction. UnitedHealth's four-star share is estimated to fall to approximately 67% from 81%, whilst CVS Health's drops to around 70% from 84%. CVS shares declined roughly 3%.

Yahoo Finance
Sep 13th, 2026
US health insurers rebound as medical costs stabilise, analysts predict 16% earnings growth through 2030

The health insurance industry may have recovered from high medical costs, with analysts predicting strong growth through 2030. Morningstar forecasts 16% annual earnings per share growth for major insurers, above the industry's typical low-double-digit target. Health insurers are improving profitability by raising rates to cover increased medical utilisation. UnitedHealth Group reported over $5 billion in second-quarter net income, with its medical care ratio falling to 86.7% from 89.4% year-over-year. The outlook also improved for pharmacy benefit management operations at companies like UnitedHealth, CVS Health, and Cigna. Despite increased regulatory scrutiny, the "big three" PBMs maintain strong competitive positions. Third-quarter earnings reports next month should provide further clarity on the industry's financial health.

PR Newswire
Sep 2nd, 2026
Thyme Care raises $125M at $2B+ valuation to expand oncology care model

Thyme Care, a Nashville-based oncology company, has closed a Series E funding round of more than $125 million at a valuation exceeding $2 billion. Morgan Health led the round, with participation from CVS Health Ventures, Humana, AlleyCorp, HealthQuest Capital, Foresite Capital, Concord Health Partners, Frist Cressey Ventures, Town Hall Ventures, and a16z Bio + Health. The company now serves over 10.5 million people across all 50 US states and manages more than $7 billion in oncology spend. Thyme Care reports it is profitable with positive free cash flow whilst delivering validated reductions of 5 to 10 per cent in total cost of care. Alongside the funding, Thyme Care is establishing Thyme Companies, a parent entity that will build a portfolio of independent oncology businesses addressing care barriers. Co-founder Robin Shah will serve as executive chairman of the new entity.

Associated Press
Aug 20th, 2026
Humana appoints Dr. Shantanu Nundy as chief medical officer to lead AI and digital care strategy

Humana has appointed Dr Shantanu Nundy as Chief Medical Officer, effective 31 August. Dr Nundy, a practicing physician and healthcare executive, will help shape the company's products, platforms, and use of AI whilst bringing clinical expertise to the enterprise. He most recently served as Executive Vice President of Care Delivery and Chief Health Officer at Accolade, a healthcare navigation company. Previously, he was Managing Director for Clinical Innovation at Evolent Health, driving value-based and digital care transformation across health systems. Dr Nundy will report to Jim Rechtin, Humana's President and CEO, and join the company's Enterprise Leadership Team. He continues to practice primary care and hospital medicine.